Statement of Changes in Beneficial Ownership (4)

FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* MONKO ALEXANDER MICHAEL	2. Issuer Name and Ticker or Trading Symbol SEQUENOM INC [ SQNM ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Sr. VP, Genetic Analysis
(Last) (First) (Middle) 7875 SITIO ABETO	3. Date of Earliest Transaction (MM/DD/YYYY) 5/30/2014
(Street) CARLSBAD, CA 92009 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	5/30/2014		M		28000	A	$0	65721	D
Common Stock	5/30/2014		F ⁽¹⁾		10384	D	$3.07	55337	D
Common Stock	5/30/2014		M		19500	A	$0	74837	D
Common Stock	5/30/2014		F ⁽¹⁾		7329	D	$3.07	67508	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽²⁾	5/30/2014		M			28000	⁽³⁾	⁽³⁾	Common Stock	28000	$0	19500	D
Restricted Stock Unit	⁽²⁾	5/30/2014		M			19500	⁽³⁾	⁽³⁾	Common Stock	19500	$0	0	D
Incentive Stock Option (right to buy)	$2.08							⁽⁴⁾	8/21/2016	Common Stock	92500		92500	D
Incentive Stock Option (right to buy)	$2.08							⁽⁵⁾	8/22/2016	Common Stock	20000		20000	D
Incentive Stock Option (right to buy)	$2.27							⁽³⁾	1/31/2024	Common Stock	26697		26697	D
Incentive Stock Option (right to buy)	$4.16							⁽³⁾	1/31/2023	Common Stock	15167		15167	D
Incentive Stock Option (right to buy)	$4.92							⁽³⁾	2/6/2022	Common Stock	21197		21197	D
Incentive Stock Option (right to buy)	$4.93							⁽⁶⁾	7/9/2017	Common Stock	32957		32957	D
Incentive Stock Option (right to buy)	$5.92							⁽³⁾	8/2/2020	Common Stock	26879		26879	D
Incentive Stock Option (right to buy)	$6.7							⁽³⁾	2/13/2021	Common Stock	13265		13265	D
Incentive Stock Option (right to buy)	$8.16							⁽⁷⁾	1/28/2018	Common Stock	7801		7801	D
Incentive Stock Option (right to buy)	$25.15							⁽⁸⁾	1/15/2019	Common Stock	4336		4336	D
Non-Qualified Stock Option (right to buy)	$2.27							⁽³⁾	1/31/2024	Common Stock	28303		28303	D
Non-Qualified Stock Option (right to buy)	$4.16							⁽³⁾	1/31/2023	Common Stock	36833		36833	D
Non-Qualified Stock Option (right to buy)	$4.92							⁽³⁾	2/6/2022	Common Stock	84803		84803	D
Non-Qualified Stock Option (right to buy)	$4.93							⁽⁶⁾	7/9/2017	Common Stock	27043		27043	D
Non-Qualified Stock Option (right to buy)	$5.92							⁽⁹⁾	8/2/2020	Common Stock	23121		23121	D
Non-Qualified Stock Option (right to buy)	$6.7							⁽³⁾	2/13/2021	Common Stock	49235		49235	D
Non-Qualified Stock Option (right to buy)	$8.16							⁽⁷⁾	1/28/2018	Common Stock	32199		32199	D
Non-Qualified Stock Option (right to buy)	$25.15							⁽⁸⁾	1/15/2019	Common Stock	5664		5664	D

Explanation of Responses:
( 1)	Shares have been surrendered to the issuer to satisfy the reporting person's tax withholding obligation due on vesting of restricted stock units.
( 2)	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
( 3)	Accelerated vesting effective May 30, 2014 of all outstanding stock option and restricted stock unit grants per contractual arrangement between officer and the Company.
( 4)	25% of the shares subject to the option vested on August 22, 2007 with the remainder vesting in 36 equal monthly installments until fully vested on August 22, 2010.
( 5)	On August 22, 2006, the reporting person was granted an option to purchase 20,000 shares of common stock. The option vested in two equal installments based on SQNM's satisfaction of certain performance criteria for the year ended December 31, 2007. The performance criteria was met, resulting in 50% of the options vesting on January 29, 2008 and the remaining 50% vested on December 31, 2008.
( 6)	The shares subject to the options vested as follows: in 48 equal monthly installments commencing on 7/10/07, such that the shares subject to the option were fully vested on 7/10/11.
( 7)	The shares subject to the Stock Option vested and became exercisable in 48 equal monthly installments commencing one month after the grant date of January 29, 2008.
( 8)	The shares subject to the options vested in 48 equal monthly installments commencing on 1/16/09, such that the shares subject to the option fully vested on 1/16/13.
( 9)	The shares subject to the options vested in monthly installments commencing on 8/3/10, such that the shares subject to the option fully vested on 12/3/12.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
MONKO ALEXANDER MICHAEL 7875 SITIO ABETO CARLSBAD, CA 92009			Sr. VP, Genetic Analysis

Signatures
By: Clarke Neumann, as attorney-in-fact For: Alexander Michael Monko		6/3/2014
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.